Bioventus Inc (BVS)
11.64
+0.59
(+5.34%)
USD |
NASDAQ |
Sep 27, 16:00
11.65
+0.01
(+0.09%)
After-Hours: 20:00
Bioventus Gross Profit (TTM): 357.17M for June 30, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 357.17M |
March 31, 2024 | 342.65M |
December 31, 2023 | 328.19M |
September 30, 2023 | 316.08M |
June 30, 2023 | 321.77M |
March 31, 2023 | 329.30M |
December 31, 2022 | 331.08M |
September 30, 2022 | 344.66M |
June 30, 2022 | 339.19M |
Date | Value |
---|---|
March 31, 2022 | 318.85M |
December 31, 2021 | 302.71M |
September 30, 2021 | 288.41M |
June 30, 2021 | 271.80M |
March 31, 2021 | 235.84M |
December 31, 2020 | 233.52M |
September 30, 2020 | 233.48M |
June 30, 2020 | 217.18M |
March 31, 2020 | 213.39M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
213.39M
Minimum
Mar 2020
357.17M
Maximum
Jun 2024
295.85M
Average
317.47M
Median
Gross Profit (TTM) Benchmarks
Perspective Therapeutics Inc | -- |
Retractable Technologies Inc | 7.342M |
InfuSystems Holdings Inc | 64.27M |
Xtant Medical Holdings Inc | 68.36M |
Catheter Precision Inc | 0.402M |